Additional mechanisms contributing to CVD in patients with NAFLD include activation of the renin-angiotensin pathway, intestinal dysbiosis, and genetic and epigenetic factors [12]. This evidence concerns the gene REN and metabolic dysfunction-associated steatotic liver disease.